The state of Wisconsin currently has 6 active clinical trials seeking participants for Migraine research studies. These trials are conducted in various cities, including Milwaukee, Madison, Green Bay and Marshfield.
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Recruiting
The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents.
Gender:
All
Ages:
Between 6 years and 17 years
Trial Updated:
03/25/2024
Locations: Clinical Investigation Specialists, Inc, Kenosha, Wisconsin +3 locations
Conditions: Pediatric Migraine
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
Recruiting
This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to <12 years) and adolescents (12 to <18 years) with chronic migraine. The study hypothesis is that in pediatric participants with chronic migraine, the combined erenumab dose group has a greater reduction from baseline to week 9 through week 12 (month 3) in monthly migraine days (MMDs) when compared with placebo in the double-blind treatment phase (DBTP).
Gender:
All
Ages:
Between 6 years and 17 years
Trial Updated:
03/20/2024
Locations: Marshfield Clinic, Marshfield, Wisconsin
Conditions: Migraine
Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine
Recruiting
This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to <12 years) and adolescents (12 to <18 years) with episodic migraine. The study hypothesis is that in pediatric participants with episodic migraine, the combined erenumab dose group has a greater reduction from baseline to week 9 through week 12 (month 3) in monthly migraine days (MMDs) when compared with placebo in the double-blind treatment phase (DBTP).
Gender:
All
Ages:
Between 6 years and 17 years
Trial Updated:
03/20/2024
Locations: Marshfield Clinic, Marshfield, Wisconsin
Conditions: Migraine
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Recruiting
The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of moderate or severe migraine in children and adolescents (≥ 6 to < 18 years of age).
Gender:
All
Ages:
Between 6 years and 17 years
Trial Updated:
03/19/2024
Locations: University Hospital, Madison, Wisconsin +1 locations
Conditions: Acute Treatment of Migraine
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
Recruiting
Multi-center, prospective, randomized, placebo- and sham-controlled study to evaluate the GORE® CARDIOFORM Septal Occluder for migraine headache relief
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
02/22/2024
Locations: Aurora St Luke's Medical Center, Milwaukee, Wisconsin +1 locations
Conditions: Migraine, Patent Foramen Ovale, PFO - Patent Foramen Ovale
Peri-neural Electrical Dry Needling Migraine Treatment Study
Recruiting
This study seeks to determine the effectiveness of a specific treatment protocol using dry needling with perineural electrical stimulation in comparison to standard treatment in physical therapy for patients with migraine headaches. This will be a randomized cross-over study in which participants will be in the first arm of the study, have a washout period, then cross over to the other arm of the study.
Gender:
All
Ages:
Between 18 years and 100 years
Trial Updated:
05/06/2022
Locations: Ascension Rehabilitation Services, Milwaukee, Wisconsin
Conditions: Migraine Headache